Ukraine simplifies access of western medications to the national pharmaceutical market

The Verkhovna Rada adopted the law, which reduces the period of drug registration to 10 days and provides a simplified procedure for drugs that have already been registered in the EU, the US, Switzerland, Australia, or Canada.

Earlier The Ministry of Healthcare of Ukraine had a one month period for the decision about drugs registration.

‘It [the law] gives us an opportunity to follow the European Community model and bring to Ukraine all the drugs which Ukrainians used to buy in Hungary, Slovakia, and Slovenia, and which are considerably cheaper than the analogues here’, – the Head of the Health Service Committee of  the Verkhovna Rada Olga Bogomoletz comments.

OCT has been working in the Ukrainian market within the past 10 years. We have successfully completed more than 200 full-service projects, including the international multicenter clinical trials. Our presence extends far beyond our network of offices. Having established well-developed connections with leading Western European CROs worldwide, OCT may conduct clinical trials in any region as required. Find out more about our experience.